Literature DB >> 3319200

Intranasal drug delivery for systemic medications.

Y W Chien1, S F Chang.   

Abstract

This article is designed to provide a critical literature review on the scientific advances in intra- and transnasal drug delivery for systemic medication. The article discusses the fundamentals, developmental concepts, and biomedical assessment of the transnasal administration of systemically effective drugs which are either easily inactivated when taken orally, due to the extensive hepatic first-pass elimination, or too large in molecular size to be absorbed efficiently, except by i.v. administration.

Mesh:

Substances:

Year:  1987        PMID: 3319200

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  12 in total

1.  Effects of pH and dose on nasal absorption of scopolamine hydrobromide in human subjects.

Authors:  S Ahmed; A P Sileno; J C deMeireles; R Dua; H K Pimplaskar; W J Xia; J Marinaro; E Langenback; F J Matos; L Putcha; V D Romeo; C R Behl
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  Model of disposition of drugs administered into the human nasal cavity.

Authors:  I Gonda; E Gipps
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

3.  Characterization and Systemic Delivery of Dibenzoylmethane via the Intranasal Route.

Authors:  Deepal Vora; Anthony E Kincaid; Justin Tolman; Harsh Chauhan
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

4.  Pharmacokinetics and bioavailability of hydromorphone: effect of various routes of administration.

Authors:  S F Chang; L Moore; Y W Chien
Journal:  Pharm Res       Date:  1988-11       Impact factor: 4.200

5.  The bioavailability of intranasal lignocaine.

Authors:  J M Scavone; D J Greenblatt; D G Fraser
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

6.  Intranasal Delivery of Exendin-4 Confers Neuroprotective Effect Against Cerebral Ischemia in Mice.

Authors:  Huinan Zhang; Jingru Meng; Shimeng Zhou; Yunhan Liu; Di Qu; Ling Wang; Xubo Li; Ning Wang; Xiaoxing Luo; Xue Ma
Journal:  AAPS J       Date:  2015-12-21       Impact factor: 4.009

7.  Intranasal midazolam plasma concentration profile and its effect on anxiety associated with dental procedures.

Authors:  A H Burstein; R Modica; M Hatton; F M Gengo
Journal:  Anesth Prog       Date:  1996

8.  UDP-glucuronosyltransferase in the rat olfactory bulb: identification of the UGT1A6 isoform and age-related changes in 1-naphthol glucuronidation.

Authors:  D Gradinaru; F G Suleman; S Leclerc; J M Heydel; J P Grillasca; J Magdalou; A Minn
Journal:  Neurochem Res       Date:  1999-08       Impact factor: 3.996

9.  Absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) from rat nasal mucosa.

Authors:  M Machida; K Sano; M Arakawa; M Hayashi; S Awazu
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

10.  Enhancement of nasal delivery of a renin inhibitor in the rat using emulsion formulations.

Authors:  T T Kararli; T E Needham; G Schoenhard; D A Baron; R E Schmidt; B Katz; B Belonio
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.